Electrocardiographic Left Ventricular Hypertrophy: Looking Beyond Left Ventricular Mass provides an innovative perspective on electrocardiograms (ECGs) usage for evaluation of left ventricular hypertrophy (LVH). It links contemporary research results with clinical practice in order to advance application of this cornerstone technology. Specifically, it highlights how standard ECGs can provide unique information on the cardiac electric field in LVH patients. This book recognizes and fulfills the urgent need to change the classical diagnostic paradigms of ECG diagnosis in LVH. To do so, it turns…mehr
Electrocardiographic Left Ventricular Hypertrophy: Looking Beyond Left Ventricular Mass provides an innovative perspective on electrocardiograms (ECGs) usage for evaluation of left ventricular hypertrophy (LVH). It links contemporary research results with clinical practice in order to advance application of this cornerstone technology. Specifically, it highlights how standard ECGs can provide unique information on the cardiac electric field in LVH patients. This book recognizes and fulfills the urgent need to change the classical diagnostic paradigms of ECG diagnosis in LVH. To do so, it turns attention to so-called false-negative ECG findings that in truth provide valuable information that largely overlooked. When used to their fullest potential, these results can be used for enhanced diagnosis, selection of targeted therapy and cardiovascular risk assessment.
1. Introduction 2. Electrocardiographic criteria for left ventricular hypertrophy diagnosis 3. ST segment strain pattern in left ventricular hypertrophy 4. QT interval dynamics in left ventricular hypertrophy 5. Epidemiology and prognosis of left ventricular hypertrophy through electrocardiography: from Minnesota Code to artificial intelligence 6. Echocardiographic diagnosis of left ventricular hypertrophy and its compatibility with electrocardiographic criteria: the "false negative and false positive" electrocardiography 7. Addition of serum biomarkers carboxyterminal propeptide of procollagen type I (PICP) and NT-proBNP levels to electrocardiography criteria for detection of left ventricular hypertrophyl 8. The discrepancy between wall thickness, myocardial mass, and ECG appearances in young patients with cardiomyopathies 9. Electrocardiographic and echocardiographic differences in the athlete’s heart: a special category 10. Electrocardiographic left ventricular hypertrophy and stroke 11. Evolving left ventricular hypertrophy: heart failure 12. How far should blood pressure be lowered in middle-aged and elderly patients with hypertension and ECG-LVH? Experiences from LIFE and VALUE 13. Surgical approaches in hypertrophic cardiomyopathy treatment 14. Genetic factors influencing clinical phenotype and electrocardiographic features in left ventricular hypertrophy 15. Artificial intelligence for detecting left ventricular hypertrophy using electrocardiography 16. Technical considerations in the automated ECG diagnosis of left ventricular hypertrophy 17. Myocardial hypertrophy and ischemia: mechanisms of electrophysiological abnormalities 18. Effect of volumetric and conductivity changes in the left ventricle on QRS complex morphology in simulations 19. The variety of QRS patterns in left ventricular hypertrophy and their electrophysiological interpretation 20. Increased LV mass, electrical remodeling, and surface ECG conduction abnormalities in heart failure: implications for implantable defibrillators and cardiac resynchronization therapy
1. Introduction 2. Electrocardiographic criteria for left ventricular hypertrophy diagnosis 3. ST segment strain pattern in left ventricular hypertrophy 4. QT interval dynamics in left ventricular hypertrophy 5. Epidemiology and prognosis of left ventricular hypertrophy through electrocardiography: from Minnesota Code to artificial intelligence 6. Echocardiographic diagnosis of left ventricular hypertrophy and its compatibility with electrocardiographic criteria: the "false negative and false positive" electrocardiography 7. Addition of serum biomarkers carboxyterminal propeptide of procollagen type I (PICP) and NT-proBNP levels to electrocardiography criteria for detection of left ventricular hypertrophyl 8. The discrepancy between wall thickness, myocardial mass, and ECG appearances in young patients with cardiomyopathies 9. Electrocardiographic and echocardiographic differences in the athlete’s heart: a special category 10. Electrocardiographic left ventricular hypertrophy and stroke 11. Evolving left ventricular hypertrophy: heart failure 12. How far should blood pressure be lowered in middle-aged and elderly patients with hypertension and ECG-LVH? Experiences from LIFE and VALUE 13. Surgical approaches in hypertrophic cardiomyopathy treatment 14. Genetic factors influencing clinical phenotype and electrocardiographic features in left ventricular hypertrophy 15. Artificial intelligence for detecting left ventricular hypertrophy using electrocardiography 16. Technical considerations in the automated ECG diagnosis of left ventricular hypertrophy 17. Myocardial hypertrophy and ischemia: mechanisms of electrophysiological abnormalities 18. Effect of volumetric and conductivity changes in the left ventricle on QRS complex morphology in simulations 19. The variety of QRS patterns in left ventricular hypertrophy and their electrophysiological interpretation 20. Increased LV mass, electrical remodeling, and surface ECG conduction abnormalities in heart failure: implications for implantable defibrillators and cardiac resynchronization therapy
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
